Health
FDA approves injectable treatment for HIV patients – OutSourcing-Pharma.com
The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.
The US Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine) as a complete regimen intended to treat human immunodeficiency virus type 1 (HIV-1) infection in adults. The injectable drug is designed to replace a current antiretroviral regimen in patients who are virologically suppressed on a stable antiretroviral regimen, with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Cabenuva, a product from…
-
Noosa News13 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General11 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News12 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
